Chemical Structure : BDK inhibitor BT2
CAS No.: 34576-94-8
货号: PC-49378Not For Human Use, Lab Use Only.
BDK inhibitor BT2 is a small molecule allosteric inhibitor of BCKDC kinase (BDK, branched-chain ketoacid dehydrogenase kinase) with IC50 of 3.19 uM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥780 | In stock | |
25 mg | ¥1280 | In stock | |
50 mg | ¥1980 | In stock | |
100 mg | ¥2980 | In stock | |
250 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BDK inhibitor BT2 is a small molecule allosteric inhibitor of BCKDC kinase (BDK, branched-chain ketoacid dehydrogenase kinase) with IC50 of 3.19 uM.
BDK inhibitor BT2 significantly increases BCKDC activity in wild-type and MSUD cells the mitochondrial branched-chain α-ketoacid dehydrogenase complex (BCKDC).
BDK inhibitor BT2 binds to the same site in BDK as other known allosteric BDK inhibitors, including (S)-α-cholorophenylproprionate ((S)-CPP).
Administration of BT2 at 20 mg/kg/day to wild-type mice for 1 week leads to nearly complete dephosphorylation and maximal activation of BCKDC in heart, muscle, kidneys, and liver with reduction in plasma BCAA concentrations.
BT2 treatment reduced steatosis and/or inflammation, improved sulin sensitivity in HFD-fed and lean mice.
分子量 | 247.089 | |
分子式 | C9H4Cl2O2S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
3,6- dichlorobenzo[b]thiophene-2-carboxylic acid |
1. Shih-Chia Tso, et al. J Biol Chem. 2014 Jul 25;289(30):20583-93.
2. Bollinger E, et al. Mol Metab. 2022 Oct 8:101611.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright